Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CARA
|
Joana Goncalves
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,972 Reduced 2.51% |
$20,292
$10.29 p/Share
|
Feb 25
2022 |
|
CARA
|
Joana Goncalves
CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 20.3% |
-
|
Feb 25
2022 |
|
CARA
|
Frederique Ph.D. Menzaghi
CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct | 2,114 Reduced 1.22% |
$21,753
$10.29 p/Share
|
Feb 25
2022 |
|
CARA
|
Frederique Ph.D. Menzaghi
CHIEF SCIENTIFIC OFF,SVP-R&D |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 10.33% |
-
|
Feb 25
2022 |
|
CARA
|
Christopher Posner
PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct | 39,000 Added 16.11% |
-
|
Feb 25
2022 |
|
CARA
|
Thomas Charles Reilly
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 36.68% |
-
|
Feb 25
2022 |
|
CARA
|
Scott Terrillion
SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct | 1,972 Reduced 1.93% |
$20,292
$10.29 p/Share
|
Feb 25
2022 |
|
CARA
|
Scott Terrillion
SEC'Y; CHIEF COMPLIANCE & G.C. |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 16.34% |
-
|
Feb 25
2022 |
|
AAN
|
Rachel G George
EVP, Gen Counsel/Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct | 34,809 Added 45.26% |
$746,653
$21.45 p/Share
|
Feb 25
2022 |
|
AAN
|
Douglass L Noe
VP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct | 9,852 Added 41.69% |
$211,325
$21.45 p/Share
|
Feb 25
2022 |
|
AAN
|
Christopher K Wall
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 38,361 Added 35.89% |
$822,843
$21.45 p/Share
|
Feb 25
2022 |
|
AAN
|
Stephen W Olsen
President |
BUY
Grant, award, or other acquisition
|
Direct | 52,590 Added 31.66% |
$1,128,056
$21.45 p/Share
|
Feb 25
2022 |
|
AAN
|
Douglas A Lindsay
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 197,466 Added 33.44% |
$4,235,646
$21.45 p/Share
|
Feb 25
2022 |
|
MCS
|
Thomas F Kissinger
Sr Exec VP, Gen Counsel & Secy |
SELL
Payment of exercise price or tax liability
|
Direct | 2,165 Reduced 1.96% |
$39,143
$18.08 p/Share
|
Feb 25
2022 |
|
MCS
|
Gregory S Marcus
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 7,645 Reduced 4.77% |
$138,222
$18.08 p/Share
|
Feb 25
2022 |
|
MCS
|
Douglas A Neis
CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,027 Reduced 4.04% |
$36,648
$18.08 p/Share
|
Feb 25
2022 |
|
MCS
|
Rolando B Rodriguez
Pres. & CEO - Marcus Theatres |
SELL
Payment of exercise price or tax liability
|
Direct | 5,066 Reduced 6.43% |
$91,593
$18.08 p/Share
|
Feb 25
2022 |
|
TTI
|
Timothy C Moeller
SVP - Supply Chain & Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct | 3,033 Reduced 2.73% |
$8,917
$2.94 p/Share
|
Feb 25
2022 |
|
TTI
|
Timothy C Moeller
SVP - Supply Chain & Chemicals |
BUY
Exercise of conversion of derivative security
|
Direct | 12,931 Added 10.41% |
-
|
Feb 25
2022 |
|
TTI
|
Jacek M Mucha
VP Finance, Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,993 Reduced 4.07% |
$8,799
$2.94 p/Share
|
Feb 25
2022 |
|
TTI
|
Jacek M Mucha
VP Finance, Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,092 Added 12.07% |
-
|
Feb 25
2022 |
|
TTI
|
Brady M Murphy
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 37,421 Reduced 3.27% |
$110,018
$2.94 p/Share
|
Feb 25
2022 |
|
TTI
|
Brady M Murphy
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 143,337 Added 11.13% |
-
|
Feb 25
2022 |
|
TTI
|
Richard D O'Brien
VP-Finance & Global Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 3,006 Reduced 1.35% |
$8,838
$2.94 p/Share
|
Feb 25
2022 |
|
TTI
|
Richard D O'Brien
VP-Finance & Global Controller |
BUY
Exercise of conversion of derivative security
|
Direct | 10,135 Added 4.35% |
-
|
Feb 25
2022 |
|
TTI
|
Matthew Sanderson
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 12,938 Reduced 3.31% |
$38,038
$2.94 p/Share
|
Feb 25
2022 |
|
TTI
|
Matthew Sanderson
Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 53,128 Added 11.95% |
-
|
Feb 25
2022 |
|
TTI
|
Elijio V Serrano
Sr. Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 16,937 Reduced 1.91% |
$49,795
$2.94 p/Share
|
Feb 25
2022 |
|
TTI
|
Elijio V Serrano
Sr. Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 69,553 Added 7.26% |
-
|
Feb 25
2022 |
|
TTI
|
Shoemake Alicia R Boston
Sr. VP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 1,510 Reduced 2.76% |
$4,439
$2.94 p/Share
|
Feb 25
2022 |
|
TTI
|
Shoemake Alicia R Boston
Sr. VP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 5,089 Added 8.51% |
-
|
Feb 25
2022 |
|
HBT
|
Fred L Drake
Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 6,135 Added 19.35% |
-
|
Feb 25
2022 |
|
HBT
|
James Lance Carter
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 4,844 Added 4.16% |
-
|
Feb 25
2022 |
|
HBT
|
Patrick F Busch
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,615 Added 7.5% |
-
|
Feb 25
2022 |
|
HBT
|
Matthew J Doherty
EVP & CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 2,403 Added 3.23% |
-
|
Feb 25
2022 |
|
HBT
|
Diane H Lanier
EVP & Chief Retail Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,124 Added 4.12% |
-
|
Feb 25
2022 |
|
HBT
|
Andrea E Zurkamer
EVP & Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,009 Added 12.73% |
-
|
Feb 25
2022 |
|
HBT
|
Mark W Scheirer
EVP & Chief Credit Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,262 Added 21.65% |
-
|
Feb 25
2022 |
|
HBT
|
Lawrence J Horvath
EVP & Chief Lending Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,331 Added 4.31% |
-
|
Feb 25
2022 |
|
SXC
|
John F Quanci
Chief Technology Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 6,875 Reduced 25.66% |
$53,831
$7.83 p/Share
|
Feb 25
2022 |
|
SXC
|
John F Quanci
Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 6,875 Added 20.42% |
-
|
Feb 25
2022 |
|
SXC
|
Bonnie M Edeus
Vice President & Controller |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,605 Reduced 80.17% |
$12,567
$7.83 p/Share
|
Feb 25
2022 |
|
SXC
|
Bonnie M Edeus
Vice President & Controller |
BUY
Exercise of conversion of derivative security
|
Direct | 1,605 Added 44.5% |
-
|
Feb 25
2022 |
|
SXC
|
Katherine T Gates
CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct | 6,319 Reduced 5.45% |
$49,478
$7.83 p/Share
|
Feb 25
2022 |
|
SXC
|
Katherine T Gates
CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct | 13,358 Added 10.33% |
-
|
Feb 25
2022 |
|
SXC
|
Phillip Michael Hardesty
Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 6,114 Reduced 3.25% |
$47,873
$7.83 p/Share
|
Feb 25
2022 |
|
SXC
|
Phillip Michael Hardesty
Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 12,924 Added 6.42% |
-
|
Feb 25
2022 |
|
SXC
|
Michael G Rippey
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 45,378 Reduced 11.23% |
$355,310
$7.83 p/Share
|
Feb 25
2022 |
|
SXC
|
Michael G Rippey
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 92,987 Added 18.71% |
-
|
Feb 25
2022 |
|
RUTH
|
Susan Mirdamadi |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 12.78% |
$360,000
$24.0 p/Share
|
Feb 25
2022 |